Marjorie Taylor Greene
Trade Performance Intelligence
Score: 3/10Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
5 flagsRep. Marjorie Taylor Greene bought $1,001 - $15,000 in $CRWD on 2025-09-11, 40 days before the Foreign Robocall Elimination Act (S2666) was enacted, a bill that could increase demand for advanced analytics and fraud detection.
Rep. Marjorie Taylor Greene bought $1,001 - $15,000 in $GS on 2025-09-11, 54 days before the Merchant Banking Modernization Act (HR5291) was enacted, which extends the holding period for merchant banking investments by financial holding companies.
Rep. Marjorie Taylor Greene bought $1,001 - $15,000 in $MS on 2025-09-11, 54 days before the Merchant Banking Modernization Act (HR5291) was enacted, which extends the holding period for merchant banking investments by financial holding companies.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | Government Securities | US TREASURY BILL 09/03/2025(Government Securities) | $100K-$250K | — | — | — | Sep 11, 2025 |
| BUY | $ADBE | Adobe Inc. - Common Stock | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $GOOG | Alphabet Inc. - Class C Capital Stock | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $AMGN | Amgen Inc. - Common Stock | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $ASML | ASML Holding N.V. - New York Registry Shares | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $CRWD | CrowdStrike Holdings, Inc. - Class A Common Stock | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $DLR | Digital Realty Trust, Inc. Common Stock | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $DUK | Duke Energy Corporation | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $GS | Goldman Sachs Group, Inc. | $1K-$15K | — | — | — | Sep 11, 2025 |
| BUY | $IBIT | iShares Bitcoin Trust ETF - iShares Bitcoin Trust ETF | $1K-$15K | — | — | — | Sep 11, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Billionaires Income Tax Act
The Billionaires Income Tax Act (HR5427) proposes taxing unrealized gains annually for high-net-worth individuals, which would directly reduce disposable wealth for this demographic. This bill, currently in early stages and referred to the House Committee on Ways and Means, poses a structural headwind for companies reliant on luxury goods and financial services catering to these individuals. Financial firms like Citigroup, Goldman Sachs, Morgan Stanley, BlackRock, Blackstone, and The Carlyle Group could face reduced asset under management growth and decreased demand for their services if such a tax were enacted.
End Rent Fixing Act of 2025
The 'End Rent Fixing Act of 2025' (HR6124) aims to prohibit rental pricing algorithms, directly impacting the operational models and profitability of residential and commercial landlords. This bill, currently in the early stages of the legislative process, has a companion bill in the Senate, S3207, indicating coordinated legislative effort. Real Estate Investment Trusts (REITs) and property management software providers face potential revenue model disruption if this legislation advances.
Lowering Drug Costs for American Families Act
The Lowering Drug Costs for American Families Act directly reduces pharmaceutical company revenues by expanding federal drug price negotiation and extending Medicare inflation rebates to commercial markets. This legislation mandates significant revenue contraction for drug manufacturers and increases cost management pressure on health insurers due to new out-of-pocket limits. Pharmaceutical stocks will decline, while health insurer margins will tighten.
Biosimilar Red Tape Elimination Act
The Biosimilar Red Tape Elimination Act, HR5526, if enacted, would automatically grant interchangeability to biosimilar products, reducing market exclusivity for innovator biologic manufacturers. This bill is in the early stages, having been referred to the House Committee on Energy and Commerce on September 19, 2025. Innovator biologic manufacturers like Amgen, Johnson & Johnson, and Biogen face potential market share erosion, while biosimilar producers like Viatris and Teva could benefit.
AI-Related Job Impacts Clarity Act
The AI-Related Job Impacts Clarity Act, S3108, mandates quarterly disclosures on AI-related job changes, increasing compliance burdens and operational costs for companies heavily invested in AI. This bill, currently in the early stages of committee referral, introduces new data transparency risks for investors in AI-centric firms. Companies across all sectors utilizing AI for automation or workforce changes face direct reporting requirements.
ERISA Litigation Reform Act
The ERISA Litigation Reform Act, HR6084, strengthens pleading standards for ERISA lawsuits, directly reducing legal exposure and operational costs for financial institutions managing retirement plans. This bill immediately benefits companies acting as fiduciaries by making it harder for plaintiffs to initiate and sustain litigation. Financial institutions will see a direct reduction in legal defense expenditures and potential liability.
Water Cybersecurity Enhancement Act of 2025
The Water Cybersecurity Enhancement Act of 2025 (HR5868) has been referred to the House Committee on Energy and Commerce, aiming to extend grant eligibility for cybersecurity in community water systems through 2031. This bill, if enacted, would create sustained demand for cybersecurity services in the water infrastructure sector. Cybersecurity stocks like $CRWD, $ZS, $PANW, $FTNT, $OKTA, and $MSFT have shown mixed performance over the past 30 days, with $OKTA up 1.14% and $ZS down 13.86%.
Foreign Robocall Elimination Act
The Foreign Robocall Elimination Act establishes an interagency taskforce to combat unlawful robocalls, increasing demand for advanced analytics and fraud prevention solutions. This directly benefits cybersecurity and analytics providers while increasing compliance costs for telecommunication companies. The bill creates a new market for specialized anti-robocall technologies.
Affordable Housing Bond Enhancement Act
The Affordable Housing Bond Enhancement Act (S1511) is currently in the committee hearing/markup stage in the Senate. This bill aims to expand housing investment through mortgage revenue bonds, which could provide a tailwind for homebuilders and financial institutions involved in bond issuance. While the bill has a companion in the House, its impact is not yet reflected in the 30-day performance of homebuilders, which shows declines, or in financial institutions, which show mixed performance.
Merchant Banking Modernization Act
The Merchant Banking Modernization Act (HR5291) extends the holding period for merchant banking investments by financial holding companies from 10 to 15 years, directly increasing flexibility and potential returns for major financial institutions engaged in private equity. This regulatory change is progressing through the House, having been placed on the Union Calendar. Financial sector stocks, including $JPM, $GS, $MS, $BAC, and $WFC, have shown positive 7-day changes, indicating market optimism.
Live Charts
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.